Novartis AG
FGF21 Mimetic Antibodies and Uses Thereof
Last updated:
Abstract:
The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human .beta.-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Status:
Application
Type:
Utility
Filling date:
18 Dec 2020
Issue date:
10 Jun 2021